Alpine Global Management, LLC Cure Vac N.V. Transaction History

Alpine Global Management, LLC

  • $331 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$5.75 - $8.5 $77,889 - $115,141
13,546 New
13,546 $82,000
Q1 2022

May 13, 2022
SELL
$14.73 - $35.25 $339,276 - $811,913
-23,033 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$33.72 - $48.22 $776,672 - $1.11 Million
23,033 New
23,033 $790,000

Others Institutions Holding CVAC

# of Institutions
93
Shares Held
12.3M
Call Options Held
164K
Put Options Held
117K
View Full List

About CureVac N.V.

CVAC Quotes by TradingView
  • Ticker CVAC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,467,008
  • Market Cap $538M
  • Description
  • CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...
More about CVAC
Track This Portfolio

Track Alpine Global Management, LLC Portfolio

Follow Alpine Global Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Global Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email